Joseph A. Bauer
Tracked across 1 events · 6 articles · First seen Jun 27, 2026 · Last active Jul 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Joseph A. Bauer is the first and corresponding author of the study on NO-Cbl, making him a central figure in this medical breakthrough. His work could lead to significant advancements in glioblastoma treatment.
Jun 27, 2026 · 6 articles
90
Joseph A. Bauer authored studyNO-Cbl Shows Glioblastoma...
ERGEN INTELLIGENCE
Track Joseph A. Bauer live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard